PGR and prostate carcinoma: It has been reported that MF inhibits proliferation of certain types of hormone-dependent cancers, such as breast cancer positive for the progesterone receptor [30,31], ovarian cancer [32,33], endometrium cancer [34], prostate cancer [35] and gastric cancer [36].